7 results on '"Hooli, Basavaraj"'
Search Results
2. No Association between CALHM1 and Alzheimer's Disease Risk
- Author
-
Bertram, Lars, Schjeide, Brit-Maren M., Hooli, Basavaraj, Mullin, Kristina, Hiltunen, Mikko, Soininen, Hilkka, Ingelsson, Martin, Lannfelt, Lars, Blacker, Deborah, and Tanzi, Rudolph E.
- Published
- 2008
- Full Text
- View/download PDF
3. Adjusting heterogeneous ascertainment bias for genetic association analysis with extended families.
- Author
-
Suyeon Park, Sungyoung Lee, Young Lee, Herold, Christine, Hooli, Basavaraj, Mullin, Kristina, Taesung Park, Changsoon Park, Bertram, Lars, Lange, Christoph, Tanzi, Rudolph, and Sungho Won
- Subjects
- *
MEDICAL genetics , *HERITABILITY , *STATISTICAL power analysis , *GENETIC correlations , *MEDICAL statistics - Abstract
Background: In family-based association analysis, each family is typically ascertained from a single proband, which renders the effects of ascertainment bias heterogeneous among family members. This is contrary to case-control studies, and may introduce sample or ascertainment bias. Statistical efficiency is affected by ascertainment bias, and careful adjustment can lead to substantial improvements in statistical power. However, genetic association analysis has often been conducted using family-based designs, without addressing the fact that each proband in a family has had a great influence on the probability for each family member to be affected. Method: We propose a powerful and efficient statistic for genetic association analysis that considered the heterogeneity of ascertainment bias among family members, under the assumption that both prevalence and heritability of disease are available. With extensive simulation studies, we showed that the proposed method performed better than the existing methods, particularly for diseases with large heritability. Results: We applied the proposed method to the genome-wide association analysis of Alzheimer's disease. Four significant associations with the proposed method were found. Conclusion: Our significant findings illustrated the practical importance of this new analysis method. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
4. Adjusting heterogeneous ascertainment bias for genetic association analysis with extended families.
- Author
-
Park, Suyeon, Lee, Sungyoung, Lee, Young, Herold, Christine, Hooli, Basavaraj, Mullin, Kristina, Park, Taesung, Park, Changsoon, Bertram, Lars, Lange, Christoph, Tanzi, Rudolph, and Won, Sungho
- Abstract
Background: In family-based association analysis, each family is typically ascertained from a single proband, which renders the effects of ascertainment bias heterogeneous among family members. This is contrary to case–control studies, and may introduce sample or ascertainment bias. Statistical efficiency is affected by ascertainment bias, and careful adjustment can lead to substantial improvements in statistical power. However, genetic association analysis has often been conducted using family-based designs, without addressing the fact that each proband in a family has had a great influence on the probability for each family member to be affected. Method: We propose a powerful and efficient statistic for genetic association analysis that considered the heterogeneity of ascertainment bias among family members, under the assumption that both prevalence and heritability of disease are available. With extensive simulation studies, we showed that the proposed method performed better than the existing methods, particularly for diseases with large heritability. Results: We applied the proposed method to the genome-wide association analysis of Alzheimer’s disease. Four significant associations with the proposed method were found. Conclusion: Our significant findings illustrated the practical importance of this new analysis method. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
5. A three-dimensional human neural cell culture model of Alzheimer's disease.
- Author
-
Choi, Se Hoon, Kim, Young Hye, Hebisch, Matthias, Sliwinski, Christopher, D'Avanzo, Carla, Chen, Hechao, Hooli, Basavaraj, Asselin, Caroline, Klee, Justin B., Zhang, Can, Kovacs, Dora M., Tanzi, Rudolph E., Kim, Doo Yeon, Lee, Seungkyu, Wainger, Brian J., Woolf, Clifford J., Muffat, Julien, Peitz, Michael, and Wagner, Steven L.
- Subjects
- *
ALZHEIMER'S disease , *NEURAL stem cells , *AMYLOID beta-protein , *THREE-dimensional modeling , *CELL culture , *GLYCOGEN synthase kinase-3 , *PROGENITOR cells - Abstract
Alzheimer's disease is the most common form of dementia, characterized by two pathological hallmarks: amyloid-β plaques and neurofibrillary tangles. The amyloid hypothesis of Alzheimer's disease posits that the excessive accumulation of amyloid-β peptide leads to neurofibrillary tangles composed of aggregated hyperphosphorylated tau. However, to date, no single disease model has serially linked these two pathological events using human neuronal cells. Mouse models with familial Alzheimer's disease (FAD) mutations exhibit amyloid-β-induced synaptic and memory deficits but they do not fully recapitulate other key pathological events of Alzheimer's disease, including distinct neurofibrillary tangle pathology. Human neurons derived from Alzheimer's disease patients have shown elevated levels of toxic amyloid-β species and phosphorylated tau but did not demonstrate amyloid-β plaques or neurofibrillary tangles. Here we report that FAD mutations in β-amyloid precursor protein and presenilin 1 are able to induce robust extracellular deposition of amyloid-β, including amyloid-β plaques, in a human neural stem-cell-derived three-dimensional (3D) culture system. More importantly, the 3D-differentiated neuronal cells expressing FAD mutations exhibited high levels of detergent-resistant, silver-positive aggregates of phosphorylated tau in the soma and neurites, as well as filamentous tau, as detected by immunoelectron microscopy. Inhibition of amyloid-β generation with β- or γ-secretase inhibitors not only decreased amyloid-β pathology, but also attenuated tauopathy. We also found that glycogen synthase kinase 3 (GSK3) regulated amyloid-β-mediated tau phosphorylation. We have successfully recapitulated amyloid-β and tau pathology in a single 3D human neural cell culture system. Our unique strategy for recapitulating Alzheimer's disease pathology in a 3D neural cell culture model should also serve to facilitate the development of more precise human neural cell models of other neurodegenerative disorders. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
6. Alzheimer’s Disease Risk Gene CD33 Inhibits Microglial Uptake of Amyloid Beta.
- Author
-
Griciuc, Ana, Serrano-Pozo, Alberto, Parrado, Antonio?R., Lesinski, Andrea?N., Asselin, Caroline?N., Mullin, Kristina, Hooli, Basavaraj, Choi, Se?Hoon, Hyman, Bradley?T., and Tanzi, Rudolph?E.
- Subjects
- *
ALZHEIMER'S disease risk factors , *MEMBRANE proteins , *MICROGLIA , *AMYLOID beta-protein , *SIALIC acids , *IMMUNOGLOBULINS , *NATURAL immunity , *GENE expression - Abstract
Summary: The transmembrane protein CD33 is a sialic acid-binding immunoglobulin-like lectin that regulates innate immunity but has no known functions in the brain. We have previously shown that the CD33 gene is a risk factor for Alzheimer’s disease (AD). Here, we observed increased expression of CD33 in microglial cells in AD brain. The minor allele of the CD33 SNP rs3865444, which confers protection against AD, was associated with reductions in both CD33 expression and insoluble amyloid beta 42 (Aβ42) levels in AD brain. Furthermore, the numbers of CD33-immunoreactive microglia were positively correlated with insoluble Aβ42 levels and plaque burden in AD brain. CD33 inhibited uptake and clearance of Aβ42 in microglial cell cultures. Finally, brain levels of insoluble Aβ42 as well as amyloid plaque burden were markedly reduced in APP Swe /PS1 ΔE9 /CD33 −/− mice. Therefore, CD33 inactivation mitigates Aβ pathology and CD33 inhibition could represent a novel therapy for AD. Video Abstract: Display Omitted [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
7. Genome-wide Association Analysis Reveals Putative Alzheimer's Disease Susceptibility Loci in Addition to APOE.
- Author
-
Bertram, Lars, Lange, Christoph, Mullin, Kristina, Parkinson, Michele, Hsiao, Monica, Hogan, Meghan F., Schjeide, Brit M.M., Hooli, Basavaraj, DiVito, Jason, Ionita, luliana, Hongyu Jiang, Laird, Nan, Moscarillo, Thomas, Ohlsen, Kari L., Elliott, Kathryn, Xin Wang, Hu-Lince, Diane, Ryder, Marie, Murphy, Amy, and Wagner, Steven L.
- Subjects
- *
GENETICS , *ALZHEIMER'S disease , *GENETIC polymorphisms , *DISEASE susceptibility , *ETIOLOGY of diseases - Abstract
Alzheimer's disease (AD) is a genetically complex and heterogeneous disorder. To date four genes have been established to either cause early-onset autosomal-dominant AD (APP, PSEN1, and PSEN21-4) or to increase susceptibility for late-onset AD (APOE5). However, the heritability of late-onset AD is as high as 80%,6 and much of the phenotypic variance remains unexplained to date. We performed a genome-wide association (GWA) analysis using 484,522 single-nucleotide polymorphisms (SNP5) on a large (1,376 samples from 410 families) sample of AD families of self-reported European descent. We identified five SNPs showing either significant or marginally significant genome-wide association with a multivariate phenotype combining affection status and onset age. One of these signals (p = 5.7 x 10-14) was elicited by SNP rs4420638 and probably reflects APOE-E4, which maps 11 kb proximal (r2 = 0.78). The other four signals were tested in three additional independent AD family samples composed of nearly 2700 individuals from almost 900 families. Two of these SNPs showed significant association in the replication samples (combined p values 0.007 and 0.00002). The SNP (rsl 1159647, on chromosome 14q31) with the strongest association signal also showed evidence of association with the same allele in GWA data generated in an independent sample of -1,400 AD cases and controls (p = 0.04). Although the precise identity of the underlying locus(i) remains elusive, our study provides compelling evidence for the existence of at least one previously undescribed AD gene that, like APOE-E4, primarily acts as a modifier of onset age. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.